Y. Riemer

525 total citations
20 papers, 418 citations indexed

About

Y. Riemer is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Geriatrics and Gerontology. According to data from OpenAlex, Y. Riemer has authored 20 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Geriatrics and Gerontology. Recurrent topics in Y. Riemer's work include Opioid Use Disorder Treatment (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). Y. Riemer is often cited by papers focused on Opioid Use Disorder Treatment (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). Y. Riemer collaborates with scholars based in Austria, Germany and Italy. Y. Riemer's co-authors include Salvatore Giacomuzzi, Georg Kemmler, Hartmann Hinterhuber, W. Wolfgang Fleischhacker, Christian Barnas, Marion Pavlic, Beate Beer, Herbert Oberacher, Hanno Ulmer and Gerald Zernig and has published in prestigious journals such as PLoS ONE, Addiction and Forensic Science International.

In The Last Decade

Y. Riemer

18 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Riemer Austria 10 199 197 88 72 56 20 418
Jean Falcioni United States 7 172 0.9× 237 1.2× 66 0.8× 83 1.2× 58 1.0× 8 336
David Sinclair Finland 11 128 0.6× 261 1.3× 86 1.0× 81 1.1× 55 1.0× 15 459
Michael Gossop United Kingdom 11 302 1.5× 250 1.3× 124 1.4× 106 1.5× 39 0.7× 11 589
Bonnie B. Wilford United States 10 195 1.0× 230 1.2× 51 0.6× 64 0.9× 64 1.1× 16 524
Jennifer Casarella United States 13 270 1.4× 391 2.0× 43 0.5× 80 1.1× 103 1.8× 17 600
Tom Carnwath United Kingdom 12 255 1.3× 246 1.2× 57 0.6× 81 1.1× 37 0.7× 28 470
Norbert Loimer Austria 14 117 0.6× 290 1.5× 100 1.1× 97 1.3× 48 0.9× 29 554
John G. Gardin United States 6 166 0.8× 139 0.7× 43 0.5× 79 1.1× 29 0.5× 7 348
Peter Muhleisen Australia 8 115 0.6× 160 0.8× 76 0.9× 196 2.7× 47 0.8× 13 363
Peter A. DeMaria United States 10 116 0.6× 115 0.6× 164 1.9× 51 0.7× 68 1.2× 20 401

Countries citing papers authored by Y. Riemer

Since Specialization
Citations

This map shows the geographic impact of Y. Riemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Riemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Riemer more than expected).

Fields of papers citing papers by Y. Riemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Riemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Riemer. The network helps show where Y. Riemer may publish in the future.

Co-authorship network of co-authors of Y. Riemer

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Riemer. A scholar is included among the top collaborators of Y. Riemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Riemer. Y. Riemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beer, Beate, Marion Pavlic, Hanno Ulmer, et al.. (2013). Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study. PLoS ONE. 8(9). e75359–e75359. 54 indexed citations
2.
3.
Beer, Beate, et al.. (2010). [Impact of slow-release oral morphine on drug abusing habits in Austria].. PubMed. 24(2). 108–17. 13 indexed citations
4.
Giacomuzzi, Salvatore, et al.. (2009). Buprenorphine and Methadone Maintenance Treatment - Sexual Behaviour and Dysfunction Prevalence. Letters in Drug Design & Discovery. 6(1). 13–13. 9 indexed citations
5.
Giacomuzzi, Salvatore, et al.. (2008). Buprenorphine- and Methadone Maintenance Treatment: Influence on Aspects of Cognitive and Memory Performance. 1(1). 5–6. 5 indexed citations
6.
Giacomuzzi, Salvatore, et al.. (2007). Intramuskulärer Beikonsum von Retardiertem Morphin bei Ambulanter Opiatsubstitution mit Buprenorphin. Suchttherapie. 8(1). 41–42. 1 indexed citations
7.
Giacomuzzi, Salvatore, et al.. (2006). Opioid Addicts at Admission vs. Slow-Release Oral Morphine, Methadone, and Sublingual Buprenorphine Maintenance Treatment Participants. Substance Use & Misuse. 41(2). 223–244. 37 indexed citations
8.
Giacomuzzi, Salvatore, Marion Pavlic, Kathrin Libiseller, et al.. (2006). Maintenance Treatment of Opioid Dependence and Patterns of Non-Prescribed Drug Use: Results of a 4-Year Trial. Letters in Drug Design & Discovery. 3(10). 731–740. 1 indexed citations
9.
Giacomuzzi, Salvatore, et al.. (2005). Gender Differences in Health-Related Quality of Life on Admission to a Maintenance Treatment Program. European Addiction Research. 11(2). 69–75. 36 indexed citations
10.
Giacomuzzi, Salvatore, et al.. (2003). Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health‐related quality of life assessment. Addiction. 98(5). 693–702. 92 indexed citations
11.
Zernig, Gerald, et al.. (2003). Intravenous Drug Injection Habits: Drug Users’ Self-Reports versus Researchers’ Perception. Pharmacology. 68(1). 49–56. 34 indexed citations
12.
Riemer, Y., et al.. (2001). [Subjective wellbeing in heroin withdrawal. With methadone the patient feels better].. PubMed. 143(37). 53–53. 3 indexed citations
13.
Giacomuzzi, Salvatore, et al.. (2001). Substitutionsbehandlung und Lebensqualität: Methadon vs. retardiertes Morphinsulfat - eine Vergleichsstudie. 4 indexed citations
14.
Riemer, Y., et al.. (2001). [Subjective wellbeing and somatic markers in methadone substitution. Evaluation of 61 heroin addicts].. PubMed. 119(3-4). 103–8. 7 indexed citations
15.
Günther, V., et al.. (1993). Methadone-substitution and driving ability. Forensic Science International. 62(1-2). 63–66. 9 indexed citations
16.
Riemer, Y., et al.. (1993). A survey of drug deaths in western Austria. Forensic Science International. 62(1-2). 141–146. 4 indexed citations
17.
Riemer, Y., et al.. (1993). [Fatalities in drug-dependent patients. A critical analysis].. PubMed. 64(9). 599–605. 1 indexed citations
18.
Zangerle, Robert, Dietmar Fuchs, Gilbert Reibnegger, et al.. (1992). Trends in HIV infection among intravenous drug users in Innsbruck, Austria.. PubMed. 5(9). 865–71. 20 indexed citations
19.
Barnas, C., et al.. (1992). BENZODIAZEPINES AND OTHER PSYCHOTROPIC DRUGS ABUSED BY PATIENTS IN A METHADONE MAINTENANCE PROGRAM: FAMILIARITY AND PREFERENCE.. Clinical Neuropharmacology. 15. 110A–111A. 11 indexed citations
20.
Barnas, Christian, et al.. (1992). Benzodiazepines and Other Psychotropic Drugs Abused by Patients in a Methadone Maintenance Program. Journal of Clinical Psychopharmacology. 12(6). 397???402–397???402. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026